Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations
NCT ID: NCT05075941
Last Updated: 2023-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3811 participants
OBSERVATIONAL
2021-11-15
2021-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are :
* to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers' hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC).
* identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities
NCT05373420
Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.
NCT02819128
Observational Study of Travellers Pathologies
NCT06701890
Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status at Melun Hospital
NCT06650722
Impact of a Permanently Maintained Healthcare Multidisciplinary Facility (PASS-MULTI) on Unscheduled Readmissions at 12 Months for Persons in Precarious Situations.
NCT03986801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shelters Paris/93
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Workers' hostels Paris/93
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
travelling community IDF(77/93/95)
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Street/Camps Paris/93
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Covid Homeless and migrants Marseille
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Hostel Paris/93
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People considered as homeless (homeless, living in a camp or squat) or
* Living in adapted housing (migrant workers' hostel) or
* Housed in residences of the National System or
* Housed in a social residence such as a 115 hotel or a social housing centre
* Freely and voluntarily consenting to participate
Exclusion Criteria
* Language barrier with no in-person or telephone translation available.
* Impossibility to give free and informed consent (comprehension barrier, cognitive and/or psychiatric and/or addictive disorders, external pressure from family and friends, persons under guardianship, etc.).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Recherche en Santé Publique, France
OTHER
Medecins Sans Frontieres, Netherlands
OTHER
Médecins du Monde
OTHER
CROIX ROUGE FRANCAISE
UNKNOWN
OBSERVATOIRE DU SAMU SOCIAL
UNKNOWN
INTERLOGEMENT 93
UNKNOWN
Agence Regionale de Sante d'Ile de France
OTHER_GOV
Epicentre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabeth POULET, MD
Role: PRINCIPAL_INVESTIGATOR
Epicentre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marseille
Marseille, , France
Paris
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01960-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.